Hallmark discoveries in the biology of Wilms tumour
© 2023. Springer Nature Limited..
The modern study of Wilms tumour was prompted nearly 50 years ago, when Alfred Knudson proposed the 'two-hit' model of tumour development. Since then, the efforts of researchers worldwide have substantially expanded our knowledge of Wilms tumour biology, including major advances in genetics - from cloning the first Wilms tumour gene to high-throughput studies that have revealed the genetic landscape of this tumour. These discoveries improve understanding of the embryonal origin of Wilms tumour, familial occurrences and associated syndromic conditions. Many efforts have been made to find and clinically apply prognostic biomarkers to Wilms tumour, for which outcomes are generally favourable, but treatment of some affected individuals remains challenging. Challenges are also posed by the intratumoural heterogeneity of biomarkers. Furthermore, preclinical models of Wilms tumour, from cell lines to organoid cultures, have evolved. Despite these many achievements, much still remains to be discovered: further molecular understanding of relapse in Wilms tumour and of the multiple origins of bilateral Wilms tumour are two examples of areas under active investigation. International collaboration, especially when large tumour series are required to obtain robust data, will help to answer some of the remaining unresolved questions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Nature reviews. Urology - 21(2024), 3 vom: 25. März, Seite 158-180 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Perotti, Daniela [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 08.03.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41585-023-00824-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363410872 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363410872 | ||
003 | DE-627 | ||
005 | 20240320233539.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41585-023-00824-0 |2 doi | |
028 | 5 | 2 | |a pubmed24n1337.xml |
035 | |a (DE-627)NLM363410872 | ||
035 | |a (NLM)37848532 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Perotti, Daniela |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hallmark discoveries in the biology of Wilms tumour |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.03.2024 | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. Springer Nature Limited. | ||
520 | |a The modern study of Wilms tumour was prompted nearly 50 years ago, when Alfred Knudson proposed the 'two-hit' model of tumour development. Since then, the efforts of researchers worldwide have substantially expanded our knowledge of Wilms tumour biology, including major advances in genetics - from cloning the first Wilms tumour gene to high-throughput studies that have revealed the genetic landscape of this tumour. These discoveries improve understanding of the embryonal origin of Wilms tumour, familial occurrences and associated syndromic conditions. Many efforts have been made to find and clinically apply prognostic biomarkers to Wilms tumour, for which outcomes are generally favourable, but treatment of some affected individuals remains challenging. Challenges are also posed by the intratumoural heterogeneity of biomarkers. Furthermore, preclinical models of Wilms tumour, from cell lines to organoid cultures, have evolved. Despite these many achievements, much still remains to be discovered: further molecular understanding of relapse in Wilms tumour and of the multiple origins of bilateral Wilms tumour are two examples of areas under active investigation. International collaboration, especially when large tumour series are required to obtain robust data, will help to answer some of the remaining unresolved questions | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Williams, Richard D |e verfasserin |4 aut | |
700 | 1 | |a Wegert, Jenny |e verfasserin |4 aut | |
700 | 1 | |a Brzezinski, Jack |e verfasserin |4 aut | |
700 | 1 | |a Maschietto, Mariana |e verfasserin |4 aut | |
700 | 1 | |a Ciceri, Sara |e verfasserin |4 aut | |
700 | 1 | |a Gisselsson, David |e verfasserin |4 aut | |
700 | 1 | |a Gadd, Samantha |e verfasserin |4 aut | |
700 | 1 | |a Walz, Amy L |e verfasserin |4 aut | |
700 | 1 | |a Furtwaengler, Rhoikos |e verfasserin |4 aut | |
700 | 1 | |a Drost, Jarno |e verfasserin |4 aut | |
700 | 1 | |a Al-Saadi, Reem |e verfasserin |4 aut | |
700 | 1 | |a Evageliou, Nicholas |e verfasserin |4 aut | |
700 | 1 | |a Gooskens, Saskia L |e verfasserin |4 aut | |
700 | 1 | |a Hong, Andrew L |e verfasserin |4 aut | |
700 | 1 | |a Murphy, Andrew J |e verfasserin |4 aut | |
700 | 1 | |a Ortiz, Michael V |e verfasserin |4 aut | |
700 | 1 | |a O'Sullivan, Maureen J |e verfasserin |4 aut | |
700 | 1 | |a Mullen, Elizabeth A |e verfasserin |4 aut | |
700 | 1 | |a van den Heuvel-Eibrink, Marry M |e verfasserin |4 aut | |
700 | 1 | |a Fernandez, Conrad V |e verfasserin |4 aut | |
700 | 1 | |a Graf, Norbert |e verfasserin |4 aut | |
700 | 1 | |a Grundy, Paul E |e verfasserin |4 aut | |
700 | 1 | |a Geller, James I |e verfasserin |4 aut | |
700 | 1 | |a Dome, Jeffrey S |e verfasserin |4 aut | |
700 | 1 | |a Perlman, Elizabeth J |e verfasserin |4 aut | |
700 | 1 | |a Gessler, Manfred |e verfasserin |4 aut | |
700 | 1 | |a Huff, Vicki |e verfasserin |4 aut | |
700 | 1 | |a Pritchard-Jones, Kathy |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature reviews. Urology |d 2009 |g 21(2024), 3 vom: 25. März, Seite 158-180 |w (DE-627)NLM187700605 |x 1759-4820 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2024 |g number:3 |g day:25 |g month:03 |g pages:158-180 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41585-023-00824-0 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2024 |e 3 |b 25 |c 03 |h 158-180 |